RSS
|
Login
|
Register
HOME
SPECIALTY
Hematology-Oncology
Nurse Practitioners
OB/GYN
Pharmacists
Physician Assistants
Primary Care Physicians
Urologists
THERAPEUTIC CATEGORIES
BRAND
GENERIC
COMPARE
NEWS
Drug News
Drugs in the Pipeline
Drug Safety Alerts and Recalls
New Drug Products
Polls & Surveys
Newsletters
News from Haymarket Journals
RESOURCES
Alerts (Sponsored)
Clinical Charts
Common Medical Abbreviations
Company
Drug Monograph Format
FDA Orange Book
Pharmacology Notes
Professional Associations
Video
Blogs
MPR Publications
Customer Service
Online Banner Ad Specs
Subscribe
DOWNLOAD
CME
JOBS
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Home
> Customer Service
Customer Service
If you have qualified for a complimentary subscription, please click on your profession to get the proper customer service information for all requests or subscription updates:
Physicians
Nurse Practitioners
Physician Assistants
Customer Service for Paid Subscribers Only
Please click on the appropriate link below or call 1-800-436-9269 (M-F, 9am-5pm ET); International subscribers call 845-267-3044
SUBSCRIBE
UPDATE INFORMATION
PAY BILL
RENEW
CONTACT US
SUBSCRIBE
Monthly Prescribing Reference
Physician Assistants' Prescribing Reference
Nurse Practitioners Prescribing Reference
Hematology/Oncology Edition
Long-Term Care Edition
Obstetrician & Gynecologist Edition
Pediatrician's Edition
Pharmacists' Edition
Urologists' Edition
Residents' Edition
UPDATE INFORMATION
Monthly Prescribing Reference
Physician Assistants' Prescribing Reference
Nurse Practitioners Prescribing Reference
Hematology/Oncology Edition
Long-Term Care Edition
Obstetrician & Gynecologist Edition
Pediatrician's Edition
Pharmacists' Edition
Urologists' Edition
Residents' Edition
PAY BILL
Monthly Prescribing Reference
Physician Assistants' Prescribing Reference
Nurse Practitioners Prescribing Reference
Hematology/Oncology Edition
Long-Term Care Edition
Obstetrician & Gynecologist Edition
Pediatrician's Edition
Pharmacists' Edition
Urologists' Edition
Residents' Edition
RENEW
Monthly Prescribing Reference
Physician Assistants' Prescribing Reference
Nurse Practitioners Prescribing Reference
Hematology/Oncology Edition
Long-Term Care Edition
Obstetrician & Gynecologist Edition
Pediatrician's Edition
Pharmacists' Edition
Urologists' Edition
Residents' Edition
CONTACT US
Monthly Prescribing Reference
Physician Assistants' Prescribing Reference
Nurse Practitioners Prescribing Reference
Hematology/Oncology Edition
Long-Term Care Edition
Obstetrician & Gynecologist Edition
Pediatrician's Edition
Pharmacists' Edition
Urologists' Edition
Residents' Edition
Most Popular
Most Emailed
Most Recent
Antiemetic Medications
Catch-Up Immunization Schedule for Children
Xiaflex approved for Dupuytren's contracture
Oleptro approved for major depressive disorder (MDD)
Juvéderm XC dermal filler approved
Restylane-L and Perlane-L dermal fillers approved
Kalbitor available for hereditary angioedema (HAE)
PreNexa prenatal vitamins reformulated
Tysabri labeling to include safety information on risk of progressive multifocal leukoencephalopathy
Phase 3 study of fidaxomicin for clostridium difficile infection (CDI)
Antibiotic Formulations
Recommended Immunization Schedule for Ages 0 to 18 Years
Mood Disorder Treatments
McNeil Consumer Healthcare recalls certain over-the-counter (OTC) products
Allergic Conjunctivitis
Antiemetic Medications
Catch-Up Immunization Schedule for Children
Phase 3 study of fidaxomicin for clostridium difficile infection (CDI)
Xiaflex approved for Dupuytren's contracture
FDA warns of counterfeit Alli for weight loss
Crestor approved for cardiovascular risk reduction
Orphan drug designation granted for aerosolized alpha1-proteinease inhibitor for alpha1-antitrypsin deficiency
Phase 2 study of tesetaxel for advanced melanoma
Feraheme safety update
Tysabri labeling to include safety information on risk of progressive multifocal leukoencephalopathy
Phase 3 study of fidaxomicin for clostridium difficile infection (CDI)
Antiemetic Medications
NDA submitted for Luveniq for noninfectious uveitis
Oleptro approved for major depressive disorder (MDD)
Xiaflex approved for Dupuytren's contracture
Sponsored Links